News Foley Represents TCGX as Investor in Tourmaline Bio, Concurrent with Merger with Talaris Therapeutics Foley & Lardner LLP represented TCGX as an investor in the $75 million private placement…Louis LehotJanuary 24, 2024
News Louis Lehot Offers Insight on Corporate M&A Momentum for 2024 Foley & Lardner LLP partner Louis Lehot is quoted in the Middle Market Growth article, “Corporate M&A…Louis LehotJanuary 24, 2024
News Foley Represents TCGX as Co-Lead Investor in $150M Series B Financing for Alkeus Pharmaceuticals Foley & Lardner LLP represented TCGX as co-lead investor in the $150 million Series B…Louis LehotJanuary 23, 2024
News Foley Represents NEA as Lead Investor in Comanche Biopharma Series B Round Foley & Lardner LLP recently represented New Enterprise Associates, Inc. (NEA) as lead investor in…Louis LehotJanuary 18, 2024
Events How to Position Your Startup for Venture Capital Funding 9:00 a.m. PST - January 18, 2024 | Webinar Join Alidad Vakili, Of Counsel with Foley…Alidad VakiliJanuary 17, 2024
News Foley Represents NEA as Investor in Series B Round for Fizz Foley & Lardner LLP represented New Enterprise Associates, Inc. (NEA) as co-lead investor in the…Louis LehotJanuary 16, 2024
News Foley Represents NEA as Co-Lead Investor in Funding Round for Orby AI Foley & Lardner LLP represented NEA as co-lead investor in the latest funding round for…Louis LehotJanuary 12, 2024
News Foley Represents Customer Fulfillment Robotics Company Instock in Latest Funding Round Foley & Lardner LLP recently represented Instock Inc., an innovator in customer fulfillment robotics, in…Louis LehotJanuary 11, 2024
BlogsVideos Startup Advisors: What is a convertible note? Foley’s Startup Advisors answer questions that entrepreneurs need to know for their startup venture. We…Shabbi KhanJanuary 10, 2024
News Louis Lehot Quoted on Health Care & Life Sciences Dealmaking Outlook Foley & Lardner LLP partner Louis Lehot is quoted in the Law360 article, “Attys Hopeful For Deals…Louis LehotJanuary 5, 2024